The case for Grail stock The good news is the trial demonstrated a "substantial increase" in Stage I-II cancers, and a ...

Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, top-performing sectors, and what’s next for biotech investors.

US equity markets transitioned from a tactical rotation to a broader, more defensive retrenchment during the recent period between February 11 and March 12. Read more here.

ASX 200 energy shares outperformed for a third consecutive week, rising 6.35%, as the war in Iran continued last week.

Two recent events helped derisk the stock, and that's good news for a stock usually seen as a high risk/high reward ...

The Eaton Vance Tax-Managed Buy-Write Income Fund offers S&P 500 exposure with a call overwrite strategy. Learn more about ...

Large U.S. firms spent about $1 trillion on their own shares in 2025, according to Morningstar estimates.

In addition, we're buying 10 shares of Goldman Sachs at roughly $799, increasing its share count in the Trust to 205 and weighting in the portfolio to about 4.35%. With the S & P 500 Short Range ...

A Canadian-based mining company, Lithium Americas (NYSE:LAC), is spending at a pace that would make most pre-revenue companies flinch. With $1.3 billion to $1.6 billion in capital expenditures planned ...

The All Ordinaries Index (ASX: XAO) is in the red today, but this ASX lithium share is shooting the lights out. Here’s what’s happening.

A well-known Israeli shipping company, ZIM Integrated Shipping Services (NYSE:ZIM) is trading at $27.41, against the $35.00 per share cash offer from Hapag-Lloyd. The spread between the current price ...

By Pragyan Kalita and Prakhar Srivastava March 20 (Reuters) - Janus Living's shares rose 17.5% in their New York Stock ...